Bryan E. Garner
7 Papers
150 Citations
Bryan E. Garner is an academic researcher. The author has contributed to research in topics: Lactobacillus acidophilus & Propionibacterium freudenreichii. The author has an hindex of 3, co-authored 7 publications.
Chat about Author
Papers
Patent
Compositions and methods for inhibiting pathogenic growth
Bryan E. Garner,Douglas R. Ware +1 more
- 06 Nov 2002
TL;DR: In this article, the authors describe methods and compositions for treating an animal to inhibit the incidence and growth of E. coli O157:H7 and other pathogenic bacteria, including Propionibacterium freudenreichii and Lactobacillus acidophilus.
65
Patent
Compositions for improving the utilization of feedstuffs by ruminants
Bryan E. Garner,Douglas R. Ware +1 more
- 16 Nov 1994
TL;DR: In this article, a mixture of a lactic acid producing bacteria culture and a lactate utilizing bacteria culture was used for improving the utilization of feedstuffs by a ruminant. But this mixture was not suitable for cattle.
41
Patent
Process for improving the utilization of feedstuffs by ruminants
Douglas R. Ware,Bryan E. Garner +1 more
- 16 Nov 1994
TL;DR: A process for improving the utilization of feedstuffs by a ruminant, the process comprising the steps of mixing a lactic acid producing bacteria culture and a lactate utilizing bacteria culture, admixing these cultures with a dry formulation or an animal feedlot diet into a composition, and administering this composition orally to ruminants is described in this paper.
38
Patent
Method to enhance fat content in the milk of a diary cow
Bryan E. Garner,Douglas R. Ware +1 more
- 21 Dec 2004
TL;DR: In this article, the authors described a method of administering an amount of a lactic acid producing bacterium such as Lactobacillus acidophilus alone or in combination with a lactate utilizing bacterium, such as Propionibacterium freudenreichii effective to enhance the milk fat content of a dairy cow.
3
Patent
Compositions to inhibit pathogenic growth
Bryan E. Garner,Douglas R. Ware +1 more
- 31 Oct 2007
TL;DR: In this paper, the authors describe compositions for treating an animal to inhibit the incidence and growth of E. coli O157:H7 and other pathogenic bacteria, such as Staphylococcus aureus.
3